Early research (Phase 1)Study completedNCT03928821
What this trial is testing
Evaluating the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Combinations of Monoclonal Antibodies PGT121, PGDM1400, 10-1074, and VRC07-523LS Administered Via Intravenous Infusion in Healthy, HIV-uninfected Adult Participants
Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 27